about
In vivo immunotherapy of lung cancer using cross-species reactive vascular endothelial growth factor nanobodies.Expression and purification of functional human vascular endothelial growth factor-a121; the most important angiogenesis factor.Inhibition of angiogenesis in human endothelial cell using VEGF specific nanobody.Selection and Characterization of Specific Nanobody Against Human Immunoglobulin G.Production and Characterization of Novel Camel Single Domain Antibody Targeting Mouse Vascular Endothelial Growth Factor.Identification of the immunogenic epitopes of the whole venom component of the Hemiscorpius lepturus scorpion using the phage display peptide library.Comparison of inhibitory effect of curcumin nanoparticles and free curcumin in human telomerase reverse transcriptase gene expression in breast cancer.The first report on transcriptome analysis of the venom gland of Iranian scorpion, Hemiscorpius lepturus.Intrabody targeting vascular endothelial growth factor receptor-2 mediates downregulation of surface localization.An in-silico approach to find a peptidomimetic targeting extracellular domain of HER3 from a HER3 Nanobody.Recombinant expression and purification of functional vascular endothelial growth factor-121 in the baculovirus expression system.Corrigendum to "The first report on transcriptome analysis of the venom gland of Iranian scorpion, Hemiscorpius lepturus" [Toxicon 125 (2017) 123-130].Design of a humanized anti vascular endothelial growth factor nanobody and evaluation of its in vitro function.Oligoclonal selection of nanobodies targeting vascular endothelial growth factorDevelopment of a human scFv antibody targeting the lethal Iranian cobra (Naja oxiana) snake venomSingle-Domain Antibodies or Nanobodies: A Class of Next-Generation AntibodiesLiposomal delivery of vascular endothelial growth factor/receptors and their inhibitorsDevelopment of a mono-specific anti-VEGF bivalent nanobody with extended plasma half-life for treatment of pathologic neovascularization
P50
Q33819576-00DA30AD-C3FF-41A7-9DFF-7D5CB505BA44Q34063852-5A7CBB9A-15DB-4C24-BD90-966A34AE4FBBQ35553928-D6D1D9ED-68E2-4F96-84EC-03FAC5DE0BC8Q35668270-AD19AA52-02D7-40F9-8A5E-758B73F6606DQ36014353-9A2AF53E-E42D-492D-8AE7-98753644E8A1Q36192403-5FC18CD1-F34E-42B8-B81A-3D70158208D9Q37354790-6DC22227-A0F8-4DA8-A8CA-608BAE6FB1C4Q39200864-A2A0825A-9650-4790-A6FC-193716F35616Q40422133-7BEACE50-1C75-4F65-A136-BB1F9AC404EDQ51123704-48D497C9-3A54-466C-AC64-87D8AC10FC78Q52860846-C2D2CBDE-C00E-4CC5-989E-91A4551CAFE4Q53509593-D5F7503E-2DE1-4126-BD50-96896927F613Q55256331-A6A1B573-B0B2-4F9C-995B-DE72D1AECC33Q58566127-C3A1837A-AD91-4ABA-A81D-FF998820178EQ90771847-D651425C-EBD2-4E3C-BF7A-C17CEB83F1EDQ91446343-253C7584-D801-4EF5-9DB1-34B968CFF63CQ91850076-53B54A7A-9EF1-4B33-8850-ABE3D370B0C6Q93055506-F313C31B-2C06-4EF1-9482-B519D8F76473
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Fatemeh Kazemi-Lomedasht
@en
Fatemeh Kazemi-Lomedasht
@nl
type
label
Fatemeh Kazemi-Lomedasht
@en
Fatemeh Kazemi-Lomedasht
@nl
prefLabel
Fatemeh Kazemi-Lomedasht
@en
Fatemeh Kazemi-Lomedasht
@nl
P31
P496
0000-0002-5832-1822